BGM Group Financials

BGM

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2025 Currency USD FYE September

Financial Health Signals

Financial Profile 41/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

BGM Group has an operating margin of -2.3%, meaning the company retains $-2 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -5.6% the prior year.

Growth

BGM Group's revenue declined 46% year-over-year, from $46.5M to $25.1M. This contraction results in a growth score of 0/100.

Leverage

100

BGM Group carries a low D/E ratio of 0.21, meaning only $0.21 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 3.39, BGM Group holds $3.39 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

BGM Group's free cash flow margin of 1.2% results in a low score of 6/100. Capital expenditures of $240K absorb a large share of operating cash flow.

Piotroski F-Score Neutral

5/9

BGM Group passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.38x

For every $1 of reported earnings, BGM Group generates $-0.38 in operating cash flow ($544K OCF vs -$1.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

This page shows BGM Group (BGM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$25.1M

YoY-46.0%

5Y CAGR-11.4%

BGM Group generated $25.1M in revenue in fiscal year 2024. This represents a decrease of 46.0% from the prior year.

EBITDA

$673K

YoY+145.9%

5Y CAGR-38.0%

BGM Group's EBITDA was $673K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 145.9% from the prior year.

Free Cash Flow

$304K

YoY+129.6%

BGM Group generated $304K in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 129.6% from the prior year.

Net Income

-$1.4M

YoY+81.5%

BGM Group reported -$1.4M in net income in fiscal year 2024. This represents an increase of 81.5% from the prior year.

EPS (Diluted)

$-0.20

BGM Group earned $-0.20 per diluted share (EPS) in fiscal year 2024. This represents an increase of 81.5% from the prior year.

Cash & Debt

$9.8M

YoY+31.3%

5Y CAGR+16.4%

BGM Group held $9.8M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

BGM Group had 7M shares outstanding in fiscal year 2024. This represents a decrease of 79.8% from the prior year.

Gross Margin

16.4%

YoY+12.6pp

5Y CAGR-4.6pp

BGM Group's gross margin was 16.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 12.6 percentage points from the prior year.

Operating Margin

-2.3%

YoY+3.4pp

5Y CAGR-15.7pp

BGM Group's operating margin was -2.3% in fiscal year 2024, reflecting core business profitability. This is up 3.4 percentage points from the prior year.

Net Margin

-5.8%

YoY+11.0pp

5Y CAGR-18.6pp

BGM Group's net profit margin was -5.8% in fiscal year 2024, showing the share of revenue converted to profit. This is up 11.0 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$1.4M

YoY+139.5%

5Y CAGR+98.7%

BGM Group invested $1.4M in research and development in fiscal year 2024. This represents an increase of 139.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$240K

YoY+33.6%

5Y CAGR-17.2%

BGM Group invested $240K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 33.6% from the prior year.

BGM Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$25.1M-46.0%	$46.5M-28.3%	$64.9M+13.6%	$57.1M+14.1%	$50.0M+8.5%	$46.1M
Cost of Revenue	$21.0M-53.1%	$44.7M-23.7%	$58.6M+13.9%	$51.5M+21.1%	$42.5M+16.7%	$36.4M
Gross Profit	$4.1M+134.9%	$1.8M-71.9%	$6.2M+10.4%	$5.6M-25.2%	$7.5M-22.1%	$9.7M
R&D Expenses	$1.4M+139.5%	$568K-53.6%	$1.2M+15204.3%	$8K-85.2%	$54K+22.7%	$44K
SG&A Expenses	$2.7M-3.8%	$2.8M-31.4%	$4.1M+26.9%	$3.3M+19.2%	$2.7M-22.1%	$3.5M
Operating Income	-$564K+78.4%	-$2.6M-224.2%	$2.1M-12.0%	$2.4M-50.4%	$4.8M-22.1%	$6.2M
Interest Expense	N/A	$99K+299.0%	$25K-56.9%	$58K-76.3%	$243K+8.6%	$224K
Income Tax	-$620K-382.9%	$219K+12.8%	$194K-23.8%	$255K-70.5%	$865K-16.3%	$1.0M
Net Income	-$1.4M+81.5%	-$7.8M-822.6%	$1.1M-65.9%	$3.2M-37.7%	$5.1M-14.3%	$5.9M
EPS (Diluted)	$-0.20	$-1.08-820.0%	$0.15+66.7%	$0.09-47.1%	$0.17-5.6%	$0.18

Metric	Q2'25	Q2'24	Q3'23	Q3'22	Q3'21	Q3'20	Q3'19
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BGM Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$53.0M+3.4%	$51.3M-20.6%	$64.5M-14.4%	$75.4M+56.5%	$48.1M+36.5%	$35.3M
Current Assets	$29.8M-13.7%	$34.5M+14.9%	$30.0M-25.6%	$40.4M+7.6%	$37.5M+50.3%	$25.0M
Cash & Equivalents	$9.8M+31.3%	$7.5M-47.8%	$14.3M+36.8%	$10.5M-11.8%	$11.9M+158.3%	$4.6M
Inventory	$5.0M+1.2%	$5.0M-43.8%	$8.9M-28.9%	$12.5M+4.2%	$12.0M-4.2%	$12.5M
Accounts Receivable	$1.5M-21.9%	$2.0M+142.3%	$815K-53.0%	$1.7M+55.0%	$1.1M+85.3%	$604K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$8.9M+29.0%	$6.9M-27.8%	$9.6M-48.8%	$18.7M-3.2%	$19.3M+52.8%	$12.6M
Current Liabilities	$8.8M+31.8%	$6.7M-27.5%	$9.2M-49.5%	$18.2M-1.4%	$18.4M+58.0%	$11.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$42.7M-0.1%	$42.8M-19.3%	$53.1M-3.3%	$54.9M+110.2%	$26.1M+31.2%	$19.9M
Retained Earnings	$4.3M-26.2%	$5.9M-62.0%	$15.5M+5.5%	$14.7M+20.5%	$12.2M+61.3%	$7.6M

Metric	Q2'25	Q2'24	Q3'23	Q3'22	Q3'21	Q3'20	Q3'19
Total Assets	$207.4M+291.3%	$53.0M+3.4%	$51.3M-20.6%	$64.5M-14.4%	$75.4M+56.5%	$48.1M+36.5%	$35.3M
Current Assets	$42.9M+44.3%	$29.8M-13.7%	$34.5M+14.9%	$30.0M-25.6%	$40.4M+7.6%	$37.5M+50.3%	$25.0M
Cash & Equivalents	$9.7M-1.7%	$9.8M+31.3%	$7.5M-47.8%	$14.3M+36.8%	$10.5M-11.8%	$11.9M+158.3%	$4.6M
Inventory	$8.8M+75.2%	$5.0M+1.2%	$5.0M-43.8%	$8.9M-28.9%	$12.5M+4.2%	$12.0M-4.2%	$12.5M
Accounts Receivable	$5.5M+257.9%	$1.5M-21.9%	$2.0M+142.3%	$815K-53.0%	$1.7M+55.0%	$1.1M+85.3%	$604K
Goodwill	$135.2M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$23.9M+168.3%	$8.9M+29.0%	$6.9M-27.8%	$9.6M-48.8%	$18.7M-3.2%	$19.3M+52.8%	$12.6M
Current Liabilities	$23.6M+168.8%	$8.8M+31.8%	$6.7M-27.5%	$9.2M-49.5%	$18.2M-1.4%	$18.4M+58.0%	$11.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$182.1M+326.1%	$42.7M-0.1%	$42.8M-19.3%	$53.1M-3.3%	$54.9M+110.2%	$26.1M+31.2%	$19.9M
Retained Earnings	$3.5M-19.8%	$4.3M-26.2%	$5.9M-62.0%	$15.5M+5.5%	$14.7M+20.5%	$12.2M+61.3%	$7.6M

BGM Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$544K+74.3%	$312K-97.5%	$12.7M+3567.5%	$345K-93.2%	$5.1M+974.9%	-$580K
Capital Expenditures	$240K+33.6%	$180K-91.2%	$2.0M+36.1%	$1.5M+232.3%	$450K-27.0%	$616K
Free Cash Flow	$304K+129.6%	$132K-98.8%	$10.6M+1023.9%	-$1.1M-124.8%	$4.6M+486.6%	-$1.2M
Investing Cash Flow	$983K+120.7%	-$4.7M-45.5%	-$3.3M+86.5%	-$24.2M-6343.2%	-$376K+53.1%	-$800K
Financing Cash Flow	-$492K+83.2%	-$2.9M+50.8%	-$5.9M-124.7%	$24.0M+1020.9%	$2.1M+322.0%	$507K
Dividends Paid	N/A	$1.8M	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'25	Q2'24	Q3'23	Q3'22	Q3'21	Q3'20	Q3'19
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BGM Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	16.4%+12.6pp	3.8%-5.8pp	9.6%-0.3pp	9.9%-5.2pp	15.1%-5.9pp	21.0%
Operating Margin	-2.3%+3.4pp	-5.6%-8.9pp	3.2%-0.9pp	4.2%-5.4pp	9.6%-3.8pp	13.4%
Net Margin	-5.8%+11.0pp	-16.7%-18.4pp	1.7%-3.9pp	5.5%-4.6pp	10.1%-2.7pp	12.8%
Return on Equity	N/A	N/A	2.0%-3.7pp	5.8%-13.7pp	19.4%-10.3pp	29.7%
Return on Assets	-2.7%+12.5pp	-15.2%-16.8pp	1.7%-2.5pp	4.2%-6.3pp	10.5%-6.2pp	16.8%
Current Ratio	3.39-1.8	5.18+1.9	3.27+1.1	2.22+0.2	2.04-0.1	2.14
Debt-to-Equity	0.21+0.0	0.16-0.0	0.18-0.2	0.34-0.4	0.74+0.1	0.63
FCF Margin	1.2%+0.9pp	0.3%-16.1pp	16.4%+18.4pp	-2.0%-11.3pp	9.3%+11.8pp	-2.6%

Metric	Q2'25	Q2'24	Q3'23	Q3'22	Q3'21	Q3'20	Q3'19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.82-1.6	3.39-1.8	5.18+1.9	3.27+1.1	2.22+0.2	2.04-0.1	2.14
Debt-to-Equity	0.13-0.1	0.21+0.0	0.16-0.0	0.18-0.2	0.34-0.4	0.74+0.1	0.63
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Harrow Health Inc HROW

$1.8B

Phibro Animal PAHC

$2.1B

Avadel Pharmaceu AVDL

$2.1B

Amphastar Pharma AMPH

$1.3B

Biocryst Pharmaceuticals Inc BCRX

$1.7B

Frequently Asked Questions

What is BGM Group's annual revenue?

BGM Group (BGM) reported $25.1M in total revenue for fiscal year 2024. This represents a -46.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BGM Group's revenue growing?

BGM Group (BGM) revenue declined by 46% year-over-year, from $46.5M to $25.1M in fiscal year 2024.

Is BGM Group profitable?

No, BGM Group (BGM) reported a net income of -$1.4M in fiscal year 2024, with a net profit margin of -5.8%.

What is BGM Group's earnings per share (EPS)?

BGM Group (BGM) reported diluted earnings per share of $-0.20 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is BGM Group's EBITDA?

BGM Group (BGM) had EBITDA of $673K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is BGM Group's gross margin?

BGM Group (BGM) had a gross margin of 16.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is BGM Group's operating margin?

BGM Group (BGM) had an operating margin of -2.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is BGM Group's net profit margin?

BGM Group (BGM) had a net profit margin of -5.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is BGM Group's free cash flow?

BGM Group (BGM) generated $304K in free cash flow during fiscal year 2024. This represents a 129.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is BGM Group's operating cash flow?

BGM Group (BGM) generated $544K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are BGM Group's total assets?

BGM Group (BGM) had $53.0M in total assets as of fiscal year 2024, including both current and long-term assets.

What are BGM Group's capital expenditures?

BGM Group (BGM) invested $240K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does BGM Group spend on research and development?

BGM Group (BGM) invested $1.4M in research and development during fiscal year 2024.

How many shares does BGM Group have outstanding?

BGM Group (BGM) had 7M shares outstanding as of fiscal year 2024.

What is BGM Group's current ratio?

BGM Group (BGM) had a current ratio of 3.39 as of fiscal year 2024, which is generally considered healthy.

What is BGM Group's debt-to-equity ratio?

BGM Group (BGM) had a debt-to-equity ratio of 0.21 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is BGM Group's return on assets (ROA)?

BGM Group (BGM) had a return on assets of -2.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is BGM Group's Piotroski F-Score?

BGM Group (BGM) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BGM Group's earnings high quality?

BGM Group (BGM) has an earnings quality ratio of -0.38x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is BGM Group?

BGM Group (BGM) scores 41 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.